先天性心脏病相关肺动脉高压孕妇的母体结局
该研究回顾性(1993-2016)及前瞻性(2017-2019)纳入7家三级医院的2220例完成妊娠的先心病孕妇,其中729例合并肺动脉高压。结果显示中重度肺动脉高压孕妇母体死亡率为5.7%,轻度者结局接近无肺动脉高压者;多学科团队随访和严格产前监护与较低的不良心脏事件风险相关。
要点
- 先心病相关中重度肺动脉高压孕妇母体死亡率5.7%,轻度者未见死亡。
- 轻度肺动脉高压孕妇母体结局多数与无肺动脉高压者相似。
- 脑钠肽>100 ng/L和NYHA III-IV级独立增加不良心脏事件风险。
核心结论
- 先心病相关轻度肺动脉高压孕妇的结局优于中重度者,多数结局事件率与无肺动脉高压者相似。
- 结合肺动脉高压严重程度、脑钠肽水平和NYHA分级的风险评估有助于妊娠期风险分层。
- 多学科团队随访和严格产前监护可能有助于降低不良母体心脏事件风险。
研究设计与样本
- 回顾性(1993-2016年)及前瞻性(2017-2019年)队列研究,来自7家三级医院。
- 共纳入2220例完成妊娠的先心病孕妇,其中729例合并肺动脉高压。
- 肺动脉高压经超声心动图或右心导管诊断,分为无、轻度(右心室-右心房压差30-50 mm Hg)和中重度(压差>50 mm Hg)。
主要发现
- 母体死亡在无、轻度和中重度肺动脉高压组分别发生1例(0.1%)、0例和19例(5.7%)。
- 729例肺动脉高压患者中,619例(85%)为先心病相关肺动脉高压,110例(15%)为其他类型。
- 轻度肺动脉高压组母体死亡或心力衰竭发生率7.8%,中重度组39.6%(P<0.001)。
- 轻度组其他心脏并发症发生率9.0%,中重度组32.3%(P<0.001)。
- 轻度组产科并发症发生率5.3%,中重度组15.7%(P<0.001)。
关键数值与推荐
- 脑钠肽>100 ng/L与不良母体心脏事件独立相关(OR 1.9,95%CI 1.0-3.4,P=0.04)。
- NYHA III-IV级与不良母体心脏事件独立相关(OR 2.9,95%CI 1.6-5.3,P<0.001)。
- 多学科团队随访与较低的不良母体心脏事件风险相关(OR 0.4,95%CI 0.2-0.6,P<0.001)。
- 严格产前监护与较低的不良母体心脏事件风险相关(OR 0.5,95%CI 0.3-0.7,P=0.001)。
临床怎么用
- 对先心病合并肺动脉高压孕妇应评估肺动脉高压严重程度、脑钠肽水平和NYHA分级以进行风险分层。
- 建议多学科团队随访和严格产前监护以降低不良母体心脏事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies focused on pregnant women with congenital heart disease (CHD)-associated pulmonary hypertension (PH) are scarce and limited by small sample sizes and single-center design. This study sought to describe the pregnancy outcomes in women with CHD with and without PH. METHODS: Outcomes for pregnant women with CHD were evaluated retrospectively from 1993 to 2016 and prospectively from 2017 to 2019 from 7 tertiary hospitals. PH was diagnosed on the basis of echocardiogram or catheterization. The incidence of maternal death, cardiac complications, and obstetric and offspring complications was compared for women with CHD and no PH, mild, and moderate-to-severe PH. RESULTS: A total of 2220 pregnant women with CHD had completed pregnancies. PH associated with CHD was identified in 729 women, including 398 with mild PH (right ventricle to right atrium gradient 30-50 mm Hg) and 331 with moderate-to-severe PH (right ventricle to right atrium gradient >50 mm Hg). Maternal mortality occurred in 1 (0.1%), 0, and 19 (5.7%) women with CHD and no, mild, or moderate-to-severe PH, respectively. Of the 729 patients with PH, 619 (85%) had CHD-associated pulmonary arterial hypertension, and 110 (15%) had other forms of PH. Overall, patients with mild PH had better maternal outcomes than those with moderate-to-severe PH, including the incidence of maternal mortality or heart failure (7.8% versus 39.6%; P<0.001), other cardiac complications (9.0% versus 32.3%; P<0.001), and obstetric complications (5.3% versus 15.7%; P<0.001). Brain natriuretic peptide >100 ng/L (odds ratio, 1.9 [95% CI, 1.0-3.4], P=0.04) and New York Heart Association class III to IV (odds ratio, 2.9 [95% CI, 1.6-5.3], P<0.001) were independently associated with adverse maternal cardiac events in pregnancy with PH, whereas follow-up with a multidisciplinary team (odds ratio, 0.4 [95% CI, 0.2-0.6], P<0.001) and strict antenatal supervision (odds ratio, 0.5 [95% CI, 0.3-0.7], P=0.001) were protective. CONCLUSIONS: Women with CHD-associated mild PH appear to have better outcomes compared with women with CHD-associated moderate-to-severe PH, and with event rates similar for most outcomes with women with CHD and no PH. Multimodality risk assessment, including PH severity, brain natriuretic peptide level, and New York Heart Association class, may be useful in risk stratification in pregnancy with PH. Follow-up with a multidisciplinary team and strict antenatal supervision during pregnancy may also help to mitigate the risk of adverse maternal cardiac events.
引用
- Zhang Q, Zhu F, Shi G, et al. Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension. Circulation. 2023. PMID: 36780387. doi:10.1161/CIRCULATIONAHA.122.057987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。